Project Description

A/Prof. Marcel Dinger

Garvan Institute of Medical Research

Future of bioinformatics: how real-time data analytics, clinical data access, and machine learning are transforming medical research

Advances in single-cell sequencing analysis

Wednesday 5 July 2017

Marcel Dinger is the Founding CEO of Genome.One, Head of the Kinghorn Centre for Clinical Genomics (KCCG) at the Garvan Institute of Medical Research and conjoint Associate Professor at UNSW Australia. Genome.One is a world-class clinical genomics service and develops specialist software and analytics solutions to enable precision healthcare worldwide. Genome.One was one of the first companies in the world to implement the HiSeq X Ten genome sequencing platform, which has capacity to sequence 18,000 human genomes per year, and provide a clinical whole genome sequencing. He has worked in bioinformatics and genomics since 1998 in both commercial and academic capacities. He was awarded his PhD in 2003 from the University of Waikato in New Zealand, has published >80 papers attracting more than 10,000 citations, and is recipient of several highly competitive awards and fellowships. He is also a founder of two other successful start-up companies. In 2016, Marcel was admitted as a Fellow into the Faculty of Sciences of the Royal College of Pathologists of Australiasia and is a Graduate of the Australian Institute of Company Directors.
Numerous international initiatives are underway to develop and drive the implementation of precision healthcare, which promises increased efficiency and improved patient outcomes. Precision medicine depends on the ability to stratify patients according to some measure, to enable more specific targeting of treatment. Various ‘omic approaches are showing high utility in stratifying patients in this context and accordingly this is driving new trends in the application of bioinformatics. In this presentation, I will discuss how ‘omic and associated clinical data is used to enable precision healthcare and how this is reciprocally creating new opportunities in medical research and transforming bioinformatics practices.
Presentation slides will be available after the event.